Boardroom Alpha
Boardroom Alpha
PRGO · Additional Proxy Materials (DEFA14A) · Filed April 3, 2026

Perrigo Co PLC — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 3, 2026
Ticker
PRGO
Accession
0001585364-26-000030
Boardroom Alpha · Filing insights

Perrigo supplements proxy clarifying 2026 LTIP amendments, including share counting; no new awards will be issued under the Current Plan.

About Perrigo Co PLC
Market cap
$1.4B
1Y TSR
−55.4%
3Y TSR
−27.4%
Board grade
C-
Sector
Healthcare
CEO
Patrick Lockwood-Taylor
Last annual meeting: Apr 30, 2026 · View full Perrigo Co PLC profile →
a2026proxyfilingsuppleme
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to §240.14a-12 PERRIGO COMPANY PLC (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): ☒ No fee required ☐ Fee paid previously with preliminary materials ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11


 
PERRIGO COMPANY PLC SUPPLEMENT TO PROXY STATEMENT FILED MARCH 20, 2026 This supplements the Proxy Statement of Perrigo Company plc filed with the Securities and Exchange Commission on March 20, 2026. This supplement is being filed with the Securities and Exchange Commission and made available to shareholders on or about April 3, 2026. Clarifying Information Related to Proposal 4: Approval to Amend Long-Term Incentive Plan The Proxy Statement notes that, under the 2026 LTIP, Shares used as full or partial payment for the purchase price of Shares or tax withholding requirement with respect to either Options or Stock Appreciation Rights shall not again be available for Awards under the Plan. To clarify in the 2026 LTIP itself that Options and Stock Appreciation Rights are treated identically for this purpose, the Company is amending Section 4(3) of the 2026 LTIP that is set forth on page B-6 of Appendix B of the Proxy Statement as below: 3. COMPUTATION OF SHARES. For the purpose of computing the total number of Shares available for Awards under the Plan, there shall be counted against the above limits the number of Shares subject to issuance upon the exercise or settlement of Awards as of the dates on which such Awards are granted (subject to the limitations on share recycling set forth below). The Shares which were previously subject to Awards but were not delivered shall again be available for Awards under the Plan if any such Awards are forfeited, terminated, expire unexercised, settled in cash or exchanged for other Awards (to the extent of such forfeiture or expiration of such Awards), or if the Shares subject thereto can otherwise no longer be issued. Any Shares which are tendered by a Participant or withheld by the Company as full or partial payment to Perrigo of the purchase price of Shares or the tax withholding requirement with respect to any Awards other than Options or Stock Appreciation Rights granted under the Plan (or the Prior Plan) shall be added to the Shares available for Awards under the Plan. Notwithstanding anything to the contrary contained herein, the following Shares shall not be added to the Shares authorized for grant under the Plan: (a) Shares tendered or withheld as full or partial payment to Perrigo by a Participant of the purchase price of an Option granted under the Plan (or the Prior Plan) or the tax withholding requirement with respect to Options or Stock Appreciation Rights under the Plan (or the Prior Plan); (b) Shares subject to a Stock Appreciation Right under the Plan (or the Prior Plan) that are not issued in connection with its stock settlement on exercise thereof, and (c) Shares reacquired by the Company on the open market or otherwise using cash proceeds from the exercise of Options under the Plan (or the Prior Plan). For the avoidance of doubt, subject to and upon shareholder approval of the 2026 Plan, no new awards will be made under the Current Plan, which is the only equity compensation plan under which the Company may grant awards. The information contained in this supplement modifies or supersedes any inconsistent information contained in the Proxy Statement and should be read in conjunction with the Proxy Statement. Capitalized terms used and not otherwise defined in this supplement have the meaning given in the Proxy Statement. If you have already submitted your proxy, you do not need to take any action unless you wish to change your vote. If you wish to change your vote based on any of the information contained in this supplement, you may change your vote or revoke your proxy in accordance with the instructions in the Proxy Statement. See the section of the Proxy Statement titled “Questions and Answers and Voting Information—May I change my vote after I have mailed my signed proxy card or voted by telephone or over the Internet?”


 
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Perrigo Co PLC (PRGO)

Reference

Frequently asked questions

When did Perrigo Co PLC file this DEFA14A?
Perrigo Co PLC (PRGO) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 3, 2026. The accession number assigned by EDGAR is 0001585364-26-000030.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Perrigo supplements proxy clarifying 2026 LTIP amendments, including share counting; no new awards will be issued under the Current Plan. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Perrigo Co PLC's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Perrigo Co PLC has filed under CIK 1585364, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer